SEATTLE, March 18, 2021, (MEDGADGET) — Organ-on-a-chip Market Overview
Increasing regulatory measures on animal testing and growing complexity in therapeutic applications has led to high adoption of organ-on-a-chip technology in the healthcare sector. Organ-on-a-chip technology is a unique cell culture process that uses biomimetic microsystem as a platform. Organ-on-a-chip devices are fabricated using silicone. The technology finds application in organ transplantation and other therapeutics.
For More Information Request Sample PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/49
Organ-on-a-chip Market Dynamics
Major institutes are focused on development and commercialization of new products. For instance, Harvard’s Wyss Institute is focused on developing lung-on-chip device. Some companies such as Mimetas is currently focused on developing kidney-on-a-chip devices. This technology reduces the amount of testing carried out on animals and offers highly accurate results, which increases adoption of the technology. Moreover, major players in the market are focused on adopting collaboration and partnership strategies with universities. Such activities are expected to boost growth of the market over the forecast period.
The organ-on-a-chip technology finds application in disease modelling, patient stratification, phenotypic screening, and other applications. Majority of the demand is expected to be generated from lung-based organ culture, followed by kidney application. The organ-on-a-chip technology provides better clinical outcomes compared to petri dishes and animal testing, which can aid researchers and companies in effectively assessing the functioning of internal organs such as the brain and lungs.
Exclusive offer!!! Purchase the report at a discounted rate!!!
Apply Promo Code “CMIFIRST1000” and Get Up to 30% Discount
Quick Buy – Organ-on-a-chip Market Research Report: https://bit.ly/3bWmuyc
Increasing funding and government initiatives are expected to contribute to the market growth over the forecast period.
However, high cost associated with the technology and early stage in R&D is expected to restrict growth of the market. However, the market is expected to witness rapid growth post-2020.
Organ-on-a-chip Market – Regional Analysis
North America and Europe are expected to dominate the overall organ-on-a-chip market throughout the forecast period. The regions are early adopters of newly developed technology. Moreover, demand is expected to be further propelled by large consumer base in these regions. North America spends over 16% of its GDP on healthcare. Moreover, various research activities are carried out in the region, which is home to some of the leading players in the market. Also, organ transplant rate is high in the region. Growth of the Europe market is expected to be primarily driven by rising demand for organ-on-chip in Germany, U.K., and France.
Asia Pacific is a lucrative market for companies engaged in organ-on-a-chip industry. However, commercialization is not expected to take place in early years. As market is still in its early stage, it would take a few years before companies can expect return on profit. Japan and China are key markets in Asia Pacific. These countries account for over half of the pharmaceutical market in Asia Pacific. Also, these countries are well equipped with technologically advanced medical devices and research centers.
Organ-on-a-chip Market – Competitive Landscape
Organovo, Hepregen, Hurel Corporation, Nortis, TissUse, Tara Biosystems, and AxoSim are some of the players engaged in organ-on-a-chip market. These companies are located in North America, with most being start-ups albeit with major funding and are expected to attain major commercial success in the near future.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/organ-on-a-chip-market-49
- Major players in the market are focused on various business strategies such as merger and acquisition, in order to enhance their market presence. For instance, in March 2018, BioIVT acquired Ascendance Biotechnology to expand its drug safety testing and toxicology portfolios.
- Major players in the market are focused on various business strategies such as merger and acquisition, in order to enhance their market presence. For instance, in November 2018, BioIVT acquired Biological Specialty Corporation (BSC), which will expand its ability to offer fresh blood products.
- Major players in the market are focused on various business strategies such as hosting conferences, events, and research symposium, in order to showcase recent research advances in the market. For instance, in August 2019, BioIVT, a provider of research models for drug and diagnostic development hosted research symposium titled, ‘“Innovation in Immuno-oncology: Breaking Down the Barriers’ at Massachusetts, U.S. This event highlighted research advances with implication for clinical practices and drug discovery of immune-oncology.
Table of Content
Global Organ-on-a-chip Market Research Report
Section 1: Global Organ-on-a-chip Industry Overview
Section 2: Global Economic Impact on Organ-on-a-chip Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Organ-on-a-chip Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Organ-on-a-chip Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027